NPI: 1639132608 · UNION CITY, CA 94587 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/10/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/10/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,372 | $1.77M |
| 2019 | 23,239 | $1.31M |
| 2020 | 23,033 | $1.26M |
| 2021 | 12,700 | $1.23M |
| 2022 | 15,435 | $1.04M |
| 2023 | 13,398 | $1.17M |
| 2024 | 10,316 | $1.19M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 41,578 | 3,318 | $8.87M |
| A4657 | Syringe, with or without needle, each | 10,993 | 2,544 | $48K |
| J1270 | Injection, doxercalciferol, 1 mcg | 18,887 | 1,579 | $22K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 26,484 | 1,746 | $15K |
| J1756 | Injection, iron sucrose, 1 mg | 6,357 | 1,878 | $5K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,190 | 669 | $4K |
| 90677 | 20 | 20 | $1K | |
| 82728 | 1,482 | 1,436 | $1K | |
| 83970 | 1,092 | 1,052 | $935.94 | |
| 83550 | 1,021 | 980 | $310.87 | |
| 90662 | 28 | 28 | $297.60 | |
| 83540 | 1,477 | 1,424 | $230.63 | |
| 90674 | 51 | 51 | $118.34 | |
| 85041 | 1,409 | 1,374 | $107.39 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 163 | 138 | $94.54 |
| 85048 | 1,401 | 1,366 | $90.69 | |
| 82108 | 88 | 87 | $67.52 | |
| G0008 | Administration of influenza virus vaccine | 17 | 15 | $53.89 |
| 0250 | 2,755 | 159 | $0.00 |